A study led by Stanford Medicine found that the earliest sign of bladder cancer — blood in the urine — may be invisible to people who are colorblind, increasing their risk of dying from the disease.
Stanford’s Nuclear Medicine and Molecular Imaging program is leading theranostics- combining imaging and targeted radiotherapy to diagnose and treat cancer.
By focusing on exercise, diet and sleep, and minimizing stress, young adults can build a lifelong foundation for health as they age, Stanford Medicine clinicians say.
Stanford Medicine clinicians say that the seventh and eighth decades of our lives are the perfect time to focus on habits that will preserve independence, mobility and mental sharpness.
Sherpabodies are compact, modular platforms that can target multiple antigens with computer-like logic, potentially boosting CAR-T therapy for solid tumors.
A molecule involved in red blood cell production determines whether the immune system attacks or ignores cells in the body via peripheral immune tolerance, Stanford Medicine researchers find.
Using years smoked instead of pack-years could make lung cancer screening more accurate and equitable, helping more high-risk patients get early detection.
Although cancer incidence rises with age, the very old seem to be at less risk. A study led by Stanford University shows this phenomenon in mice and explores the protective effect of advanced age.
“The phrase ‘Sugar feeds cancer’ is a dangerous statement,” says Stanford Medicine oncology dietitian Erika Connor. “It switches people’s anxiety on and sets them up for misinformation and panic.”
Stanford leads the world in biology-guided radiotherapy, using RefleXion technology to image tumors in real time and deliver ultra-precise, targeted radiation.
Many people are turning to marijuana for medical purposes and it may help for some. But older adults, in particular, should be aware of the risks to their health, Stanford Medicine experts caution.
5-10% of breast cancers are due to genetic factors, and being able to implement effective genetic testing could let ~4 million people know about their risk.
The new issue of Stanford Medicine magazine explores advances in diagnostics, prevention and therapy that are lifting the burden of chronic conditions.
The cellular pathways linking wildfire smoke exposure to disease are just starting to be uncovered. A Stanford Medicine researcher explains what the knowledge will mean for heading off disease.
Small cell lung cancer often metastasizes to the brain. A Stanford Medicine-led study shows the cancer cells form synapses with neurons, and signaling across these synapses encourages tumor growth.
The Stanford Cancer Institute hosted undergraduate students across the Bay Area for the inaugural Stanford Cancer Research and Careers Undergraduate Program.
Fewer than half of people diagnosed with a subtype of myeloid/lymphoid neoplasms are alive one year later. A multicenter Phase 2 trial led by Stanford Medicine leads to FDA approval of new drug treatment.
Is a nightly glass of wine — or two, even — good for you? Bad for you? Or somewhere in between? Stanford experts discuss the health implications of moderate alcohol consumption and how the guidelines have changed.
Like many among her generation, Kim Ratcliff grew up largely unaware of the dangers of sunbathing. When she got diagnosed with stage III melanoma, a team of Stanford Medicine doctors stepped in to help.
New tools reveal how ribosomes — the cell’s protein factories — specialize in ways that could unlock treatments for cancer, neurodegenerative diseases, and more. Maria Barna and team are digging deep.
Matching grant from Weill family creates collaborative research hub, uniting scientists from Stanford Medicine and UCSF to transform cancer care within a decade.
mRNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers tracked the in situ CAR-T cells to assess their effectiveness and safety.
A Stanford Medicine research dietitian spells out what ultra-processed means, why such foods are unhealthy and how to eat a healthy diet in a world filled with them.
A team of Stanford cancer scientists has been awarded to develop AI models that integrate different data types and identify biomarkers to predict whether a patient will respond to a specific cancer treatment.
His gift to the world was a poignant telling of a promising young life taken by cancer a decade ago. Still today, the Stanford Medicine neurosurgeon's wife Lucy receives notes of gratitude weekly.
Stanford Cancer Institute member Brendan Visser discusses the challenges inherent in pancreatic cancer treatment and how patient outcomes can be improved.
Somehow, the idea that we need to protect our skin from the sun has blurred in recent years — largely due to online misinformation. We asked dermatologists about the science on sunscreen products.
When Gita Abhiraman was a child, an early form of immunotherapy saved her mother’s life. She has dedicated her career to finding innovative treatments that could help others.
Stanford chemical biologist Carolyn Bertozzi studies sugars on the surface of cells to better understand their involvement in diseases, including cancer. This work aims to add to our fundamental knowledge of biology while also informing new medical treatments.
November 20, 2025 | Stanford Cardiovascular Institute
The Office of Communication & Public Affairs is dedicated to sharing School of Medicine news with the media and helping journalists secure expert interviews, photographs and rich media for stories on medicine and health care.
